Post-earnings recap
Reported
Wed, May 10, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported a narrower-than-expected loss per share, which led to a positive stock reaction, with shares rising by 2.08%. However, there was no revenue reported or guidance provided, leaving investors with limited insight into future performance. The EPS surprise suggests some level of operational efficiency, but the lack of additional information may leave investors cautious.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.79 | N/A | +15.72% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.